New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Study shows potential for new radiopharmaceutical cancer treatment

Study shows potential for new radiopharmaceutical cancer treatment

by Elizabeth Chapin,University of KentuckyGastrin- releasing peptide receptor (GRPR) immunoreactivity in uterine cervix cancer. Hematoxylin and eosin (H&E) staining of uterine cervix cancer
Oncology February 20,2024
Study shows potential for new radiopharmaceutical cancer treatment

Study shows potential for new radiopharmaceutical cancer treatment

by Elizabeth Chapin,University of KentuckyGastrin- releasing peptide receptor (GRPR) immunoreactivity in uterine cervix cancer. Hematoxylin and eosin (H&E) staining of uterine cervix cancer
Oncology February 20,2024
Study shows promising results for immunotherapy targeting skin cancer

Study shows promising results for immunotherapy targeting skin cancer

by King's College LondonCSPG4 expression in malignant melanoma and normal tissues.aCSPG4 mRNA expression, derived from RNAseq data, across cell lines of different cancer cell type
Oncology February 20,2024
Study shows promising results for immunotherapy targeting skin cancer

Study shows promising results for immunotherapy targeting skin cancer

by King's College LondonCSPG4 expression in malignant melanoma and normal tissues.aCSPG4 mRNA expression, derived from RNAseq data, across cell lines of different cancer cell type
Oncology February 20,2024
Travel time for breast cancer screening remains long for many women in the US, new study shows

Travel time for breast cancer screening remains long for many women in the US, new study shows

by American Cancer SocietyA new study led by researchers at the American Cancer Society shows travel time to the nearest mammography facility is long for a considerable proportion of women in the
Oncology February 20,2024
Travel time for breast cancer screening remains long for many women in the US, new study shows

Travel time for breast cancer screening remains long for many women in the US, new study shows

by American Cancer SocietyA new study led by researchers at the American Cancer Society shows travel time to the nearest mammography facility is long for a considerable proportion of women in the
Oncology February 20,2024
Study examines Kentucky cancer survivors' increased risk of cancer incidence

Study examines Kentucky cancer survivors' increased risk of cancer incidence

by Elizabeth Chapin,University of KentuckyCredit: Unsplash/CC0 Public DomainWhile cancer survivors have an increased risk of developing cancer in the future, that risk is notably higher in Kentu
Oncology February 20,2024
Study examines Kentucky cancer survivors' increased risk of cancer incidence

Study examines Kentucky cancer survivors' increased risk of cancer incidence

by Elizabeth Chapin,University of KentuckyCredit: Unsplash/CC0 Public DomainWhile cancer survivors have an increased risk of developing cancer in the future, that risk is notably higher in Kentu
Oncology February 20,2024
Researchers identify protein with DYRK1A-inhibiting effect that may have implications for Down syndrome

Researchers identify protein with DYRK1A-inhibiting effect that may have implications for Down syndrome

by Kyoto UniversityDYRK1A bound to FAM53C in the cytoplasm is less active. DYRK1A not bound to FAM53C in the nucleus is highly active. Functional abnormalities cause various neuropsychiatric deve
Oncology February 20,2024
Researchers identify protein with DYRK1A-inhibiting effect that may have implications for Down syndrome

Researchers identify protein with DYRK1A-inhibiting effect that may have implications for Down syndrome

by Kyoto UniversityDYRK1A bound to FAM53C in the cytoplasm is less active. DYRK1A not bound to FAM53C in the nucleus is highly active. Functional abnormalities cause various neuropsychiatric deve
Oncology February 20,2024
Researchers identify drug resistance factors for advanced prostate cancer

Researchers identify drug resistance factors for advanced prostate cancer

by Mayo ClinicThe DNA/RNA processing used both single sample and multi-sample analyses as part of the processing. Credit:Molecular Cancer Research(2022). DOI: 10.1158/1541-7786.MCR-22
Oncology February 20,2024
Researchers identify drug resistance factors for advanced prostate cancer

Researchers identify drug resistance factors for advanced prostate cancer

by Mayo ClinicThe DNA/RNA processing used both single sample and multi-sample analyses as part of the processing. Credit:Molecular Cancer Research(2022). DOI: 10.1158/1541-7786.MCR-22
Oncology February 20,2024
French Polynesia nuke tests slightly increased cancer risk: Study

French Polynesia nuke tests slightly increased cancer risk: Study

Underground nuclear tests in French Polynesia in 1985 have been a source of friction between Paris and the archipelago.Polynesians exposed to fallout from France's nuclear tests in the South Pacif
Oncology February 20,2024
French Polynesia nuke tests slightly increased cancer risk: Study

French Polynesia nuke tests slightly increased cancer risk: Study

Underground nuclear tests in French Polynesia in 1985 have been a source of friction between Paris and the archipelago.Polynesians exposed to fallout from France's nuclear tests in the South Pacif
Oncology February 20,2024
The importance of nutrition and physical activity for cancer patients and their caregivers

The importance of nutrition and physical activity for cancer patients and their caregivers

by Drexel UniversityCredit: Unsplash/CC0 Public DomainIt is well known that a healthy diet and physical activity are beneficial to cancer survivorship. But support for the physical and dietary he
Oncology February 20,2024
The importance of nutrition and physical activity for cancer patients and their caregivers

The importance of nutrition and physical activity for cancer patients and their caregivers

by Drexel UniversityCredit: Unsplash/CC0 Public DomainIt is well known that a healthy diet and physical activity are beneficial to cancer survivorship. But support for the physical and dietary he
Oncology February 20,2024
Examining how gender inequalities worsen women's access to cancer prevention, detection and care

Examining how gender inequalities worsen women's access to cancer prevention, detection and care

by LancetWomen, power, and cancer: a Lancet Commission highlights how, at all these intersections with cancer, women across the globe are subject to overlapping forms of discrimination and inequi
Oncology February 20,2024
Examining how gender inequalities worsen women's access to cancer prevention, detection and care

Examining how gender inequalities worsen women's access to cancer prevention, detection and care

by LancetWomen, power, and cancer: a Lancet Commission highlights how, at all these intersections with cancer, women across the globe are subject to overlapping forms of discrimination and inequi
Oncology February 20,2024
AI better than human eye at predicting brain metastasis outcomes, find researchers

AI better than human eye at predicting brain metastasis outcomes, find researchers

by York UniversityArchitecture of (a) vanilla 3D residual network (baseline), (b) the 3D residual network with CBAM attention, (c) the proposed self-attention-guided 3D residual network, (d) the
Oncology February 20,2024
AI better than human eye at predicting brain metastasis outcomes, find researchers

AI better than human eye at predicting brain metastasis outcomes, find researchers

by York UniversityArchitecture of (a) vanilla 3D residual network (baseline), (b) the 3D residual network with CBAM attention, (c) the proposed self-attention-guided 3D residual network, (d) the
Oncology February 20,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com